Stepping before the investment community at the UBS Warburg Conference in New York this week, Howard Robin, president and CEO of Sirna, touted the company’s strong cash position and technical experience with RNA.
Robin noted that, between an April private placement of $48 million of stock and warrants and a $5 million rights offering in July, Sirna has raised $53 million this year. As of June 30, the company — which burns about $1.5 million a month — had about $43.8 million in cash, cash equivalents, and securities for sale.